Zions Bancorporation, N.A. Bausch Health Companies Inc. Transaction History

Zions Bancorporation, N.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$4.58 - $9.21 $5,743 - $11,549	1,254 New	1,254 $9,000
Q2 2022 Aug 05, 2022	SELL	$7.06 - $23.63 $4,087 - $13,681	-579 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $410 - $528	19 Added 3.39%	579 $13,000
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $4,048 - $5,105	176 Added 45.83%	560 $15,000
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $238 - $322	16 Added 4.35%	384 $6,000
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $505 - $779	-38 Reduced 9.36%	368 $7,000
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $623 - $1,452	48 Added 13.41%	406 $6,000
Q3 2019 Nov 13, 2019	BUY	$20.88 - $25.66 $7,475 - $9,186	358 New	358 $8,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.